NLS Pharmaceutics Ltd. (NASDAQ:NLSP) Short Interest Update

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) was the target of a significant drop in short interest in the month of July. As of July 15th, there was short interest totalling 544,900 shares, a drop of 89.5% from the June 30th total of 5,170,000 shares. Based on an average trading volume of 9,700,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 1.9% of the company’s shares are sold short.

NLS Pharmaceutics Stock Performance

Shares of NASDAQ:NLSP traded down $0.01 during trading on Thursday, reaching $0.20. 505,171 shares of the company were exchanged, compared to its average volume of 4,696,852. The business’s fifty day simple moving average is $0.18 and its 200-day simple moving average is $0.26. NLS Pharmaceutics has a 12-month low of $0.11 and a 12-month high of $1.21.

NLS Pharmaceutics Company Profile

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).